浏览量: 89
- 产品名称: Research Grade Caplacizumab ( 卡拉西单抗 )
- 产品货号: CSD00272
- 货期: 现货
- 价格与订购: 2480
- 数量:
- 规格: 100μg
- 产品信息
- 如何订购
货号(Catalog No.)
CSD00272
通用名INN
Caplacizumab
纯度(Purity)
>95%
电泳图(SDS-PAGE image)
icon
浓度( Concentration)
1mg/ml
Formulation
PBS buffer PH7.5
Source
CHO cells
内毒素(Endotoxin level)
Please contact with the lab for this information.
产品描述(Description)
Caplacizumab, firstly called ALX-0081, is a humanized single-variable-domain immunoglobulin consisting of two identical humanized building blocks genetically linked by a three-alanine linker. Caplacizumab was developed by Ablynx, a Sanofi company and FDA approved on February 6, 2019,6 and approved previously by the EU in October 2018 as a combination therapy with plasma exchange and immunosuppression.
别名(Alternative names)
ALX-0081,PMP12A2h1-linker AAA-PMP12A2h1,caplacizumab-yhdp
靶点;物种(Specificity target name;species)
VWF A1 domain[Homo sapiens]
种类(Species)
Humanized
受体鉴定(Receptor identification)
VH-VH
分子量(MV)
27880.0 Da
CAS
915810-67-2
存储条件(Storage)
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Store at +4°C short term (1-2 weeks).
Store at -20 °C 12 months.
Store at -80°C long term.
Note
For research use only .